VisionGate Raises $2M For Lung Cancer Diagnostics

Phoenix-based VisionGate, a developer of non-invasive test for the early detection of lung cancer, said today that it has raised $2M in a first tranche of a financing round. According to the firm, the funding comes as part of an ongoing $3M funding round, and came from both new and existing investors. Names of the investors in the round were not announced. More information »